Veru Reports Third Quarter Fiscal 2022 Financial Results; Progresses Sabizabulin Treatment for COVID-19 Towards Regulatory Decisions in Key Territories

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. COHR
9. META
10. AMC

Go back to Veru Reports Third Quarter Fiscal 2022 Financial Results; Progresses Sabizabulin Treatment for COVID-19 Towards Regulatory Decisions in Key Territories
(NASDAQ: VERU) Delayed: 2.44 +0.03 (1.24%)
Previous Close $2.41    52 Week High $ 
Open $2.44    52 Week Low $ 
Day High $2.49    P/E N/A 
Day Low $2.43    EPS $ 
Volume 158,217